Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2019

Open Access 01-12-2019 | Correction

Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals

Authors: Abdel-Moneim M. Osman, Suad A. Telity, Zoheir A. Damanhouri, Sameer E. Al-Harthy, Huda M. Al-Kreathy, Wafaa S. Ramadan, Mohamed F. Elshal, Lateef M. Khan, Fatemah Kamel

Published in: Cancer Cell International | Issue 1/2019

Login to get access

Excerpt

Following publication of the original article [1], the authors notified us of an error in the spelling of second author’s name. The correct name spelling is Suad A. Telity. …
Literature
1.
Metadata
Title
Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals
Authors
Abdel-Moneim M. Osman
Suad A. Telity
Zoheir A. Damanhouri
Sameer E. Al-Harthy
Huda M. Al-Kreathy
Wafaa S. Ramadan
Mohamed F. Elshal
Lateef M. Khan
Fatemah Kamel
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2019
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-019-0750-0

Other articles of this Issue 1/2019

Cancer Cell International 1/2019 Go to the issue

Primary research

Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway

Primary research

miR-145 supports cancer cell survival and shows association with DDR genes, methylation pattern, and epithelial to mesenchymal transition

Primary research

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer

Primary research

Expression of ANGPTL2 and its impact on papillary thyroid cancer

Primary research

LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p

Primary research

LncRNA DANCR promotes the proliferation, migration, and invasion of tongue squamous cell carcinoma cells through miR-135a-5p/KLF8 axis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits